Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Guo-Wang Yang"'
Autor:
Chao Deng, Qing Liu, Meng Yang, Hui-juan Cui, Yang Ge, Qin Li, Shi-jie Zhu, Guo-wang Yang, Zhi-guo Zhang, Yu Gao, Yan-ni Lou, Li-qun Jia
Publikováno v:
Chinese Medicine, Vol 19, Iss 1, Pp 1-12 (2024)
Abstract Background Irinotecan is a standard chemotherapeutic agent in small cell lung cancer (SCLC), however, as a common adverse reaction, diarrhea limits the use of irinotecan. Shengjiang Xiexin decoction (SXD) has been used in various gastrointes
Externí odkaz:
https://doaj.org/article/0d99041e16174103aac2d1340798dd8f
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Osimertinib is regarded as a promising third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) for advanced non-squamous non-small cell lung cancer (NSCLC) patients who developed T790M. However the
Externí odkaz:
https://doaj.org/article/6996ef91c85145fe9062d1dc442c2a75
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e36186- (2024)
Background: Multimodal analgesia plays a key role in enhanced recovery after surgery. Herein, we describe a trial protocol investigating the effects of oxycodone-vs. sufentanil-based patient-controlled analgesia in combination with quadratus lumborum
Externí odkaz:
https://doaj.org/article/5514d6aa09ee4d3fac3da4abff4ece65
Autor:
Qi-Wei Li, Ming-Wei Yu, Xiao-Min Wang, Guo-Wang Yang, Huan Wang, Chen-Xi Zhang, Na Xue, Wei-Ru Xu, Yi Zhang, Pei-Yu Cheng, Lin Yang, Qi Fu, Zhong Yang
Publikováno v:
Chinese Medicine, Vol 15, Iss 1, Pp 1-11 (2020)
Abstract Background Chemotherapy-induced nausea and vomiting (CINV) is a common and distressing side effect. We conducted this clinical trial to compare the effectiveness of true acupuncture vs. sham acupuncture in controlling chemotherapy-induced na
Externí odkaz:
https://doaj.org/article/c7b98e90970744129f84c79dd536ef7a
Autor:
Wen‐Jing Yang, Hai‐Bo Wang, Wen‐Da Wang, Peng‐Yu Bai, Hong‐Xia Lu, Chang‐He Sun, Zi‐Shen Liu, Ding‐Kun Guan, Guo‐Wang Yang, Gan‐Lin Zhang
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 179-193 (2020)
Abstract The current criteria for defining the recurrence risks of stage II colorectal cancer (CRC) are not robust; therefore, we aimed to explore novel gene signatures to predict recurrence risks and to reveal the underlying mechanisms of stage II C
Externí odkaz:
https://doaj.org/article/b1562b735de94fd797cd607bdb401d6c
Autor:
Qi-wei Li, Ming-wei Yu, Guo-wang Yang, Xiao-min Wang, Huan Wang, Chen-xi Zhang, Na Xue, Wei-ru Xu, Qi Fu, Zhong Yang, Lin Yang
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-8 (2017)
Abstract Background Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and distressing side effects in patients with cancer. The introduction and development of antiemetic drugs have significantly improved the ability of clinic
Externí odkaz:
https://doaj.org/article/685c6ceb72f940699e325dd3bcc94122
Autor:
Yi Zhang, Gan-Lin Zhang, Xu Sun, Ke-Xin Cao, Ya-Wen Shang, Mu-Xin Gong, Cong Ma, Nan Nan, Jin-Ping Li, Ming-Wei Yu, Guo-Wang Yang, Xiao-Min Wang
Publikováno v:
Molecules, Vol 22, Iss 5, p 787 (2017)
Gubenyiliu II (GYII), a Traditional Chinese Medicine (TCM) formula used in our hospital, has shown beneficial effects in cancer patients. In this study, we investigated the molecular mechanisms underlying the beneficial effects of GYII on murine brea
Externí odkaz:
https://doaj.org/article/858eea67a41846ec89097bce49688461
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background The application of radiotherapy (RT) in pancreatic cancer remains controversial. Aim The aim of the study was to evaluate the efficacy of radiotherapy (neoadjuvant and adjuvant radiotherapy) for resectable I/II pancreatic cancer.
Externí odkaz:
https://doaj.org/article/001658abc48e4211a4ad17458fd6e394
Publikováno v:
Aging (Albany NY)
Heparanase (HPSE), an endoglycosidase that cleaves heparan sulfate, regulates a variety of biological processes that promote tumor progression. In this study, we analyzed the correlation between HPSE expression and prognosis in cancer patients, using
Publikováno v:
BioMed Research International, Vol 2021 (2021)
BioMed Research International
BioMed Research International
Background. The hypercoagulable status, which forms a vicious cycle with hematogenous metastasis, is a common systemic alteration in cancers. As modeling is a key approach in research, a model which is suitable for studying how the hypercoagulable st